The Effect of Radiation Timing on Patients With High-Risk Features of Parameningeal Rhabdomyosarcoma: An Analysis of IRS-IV and D9803
Aaron C. Spalding(Kosair Children's Hospital), Jeff M. Michalski(Washington University in St. Louis), Sarah S. Donaldson(Stanford University), James R. Anderson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Douglas S. Hawkins(Seattle Children's Hospital), Fran Laurie(University of Massachusetts Chan Medical School), Carola A.S. Arndt(Mayo Clinic in Florida), Elizabeth Lyden(University of Nebraska Medical Center)
International Journal of Radiation Oncology*Biology*Physics
September 26, 2013
Cited by 51
Related Papers
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
|Journal of Clinical Oncology|2017|485